Sector
PharmaceuticalsOpen
₹24.55Prev. Close
₹24.17Turnover(Lac.)
₹20.34Day's High
₹25Day's Low
₹23.4552 Week's High
₹35.8852 Week's Low
₹19Book Value
₹-7.53Face Value
₹10Mkt Cap (₹ Cr.)
105.01P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 43.18 | 43.18 | 43.18 | 43.18 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 44.62 | 62.17 | -9.14 | -22.71 |
Net Worth | 87.8 | 105.35 | 34.04 | 20.47 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 85.33 | 66.83 | 34.79 | 124.18 |
yoy growth (%) | 27.67 | 92.06 | -71.97 | -3 |
Raw materials | -81.21 | -55.96 | -26.97 | -89.85 |
As % of sales | 95.17 | 83.73 | 77.51 | 72.35 |
Employee costs | -14.44 | -11.37 | -10.3 | -10.21 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -24.2 | -14.2 | -7.95 | 9.22 |
Depreciation | -0.23 | -0.23 | -0.41 | -0.57 |
Tax paid | 6.09 | 3.99 | 3.69 | -2.71 |
Working capital | 1.81 | -30.33 | -7.03 | -6.6 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 27.67 | 92.06 | -71.97 | -3 |
Op profit growth | 100.53 | 26.74 | -166.69 | -270.92 |
EBIT growth | 105.36 | 30.82 | -155.99 | -299.94 |
Net profit growth | 77.37 | 139.6 | -165.46 | -204.85 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Y K Gupta
Company Sec. & Compli. Officer
Sandip K Lal
Independent Director
Alka Sharma
Independent Director
Mohd Aslam
Independent Director
Sudhanshu Vrati
Independent Director
Madhu Dikshit
Managing Director
Sanjay Kumar Mishra
Independent Director
Pankaj Kumar
BIBCOL OPV Plant Village Chola,
Uttar Pradesh - 203203
Tel: 91-5732-238210
Website: http://www.bibcol.com
Email: sklalacs@yahoo.co.in
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was incorporat...
Read More
Reports by Bharat Immunological & Biological Corporation Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.